Condition

Solid Cancers clinical trials and research

• 13Clinical trials
• 6NIH research projects
• 6Countries

Newest Solid Cancers clinical trials

All recruiting trials (13)

• Clonal Hematopoiesis Effects with Chemo and Radiation in Solid Cancers

  This study tests whether clonal hematopoiesis affects outcomes for adults with solid cancers who are receiving chemotherapy or radiation.

  Recruiting Dana-Farber Cancer Institute · Boston, Massachusetts · NCT07675967

• Using a weighted blanket to help cancer patients during IV therapy

  A randomized study tests whether wearing a weighted blanket during IV cancer treatment reduces anxiety, stress, and depression and increases comfort compared with standard blankets.

  Recruiting Sultan Qaboos Comprehensive Cancer Center · Muscat, Seeb · NCT07653035

• JY016 injection for EGFR-positive advanced solid tumors

  This study tests JY016 injections in adults with EGFR-expressing advanced solid cancers to see if it is safe and potentially effective.

  Recruiting Phase 1/2 Biotech Pharmaceutical Co., Ltd. · Beijing, Beijing Municipality · NCT07510841

• Antibody-armored dendritic cell therapy for people with solid tumors

  This will test a single injection of antibody-armored dendritic cells in adults with certain resected solid tumors after standard adjuvant chemotherapy to see if it is safe and stimulates an immune response.

  Recruiting Phase 1 Shanghai Cell Therapy Group Co.,Ltd · Shanghai · NCT07479667

• Biomarkers and immune responses in early-stage solid cancers treated with immunotherapy

  This study tests immune biomarkers in patients with early-stage solid cancers who are receiving immune checkpoint blockade before surgery.

  Recruiting Institut Claudius Regaud · Toulouse and 2 other locations · NCT07427186

• TCC1727 combined with other cancer medicines for adults with advanced solid tumors

  This phase Ib/II trial tests TCC1727 given with benmelstobart, olaparib, or topotecan in adults with advanced solid tumors to find safe doses and see if the combinations help control tumors.

  Recruiting Phase 1/2 Beijing Tide Pharmaceutical Co., Ltd · Beijing, Beijing Municipality and 2 other locations · NCT07371663

• Predicting immune-related side effects in solid cancers treated with immune therapy

  This study tests whether a baseline biological signature can predict immune-related adverse events in adults with solid tumors who are starting immune checkpoint inhibitors.

  Recruiting Assistance Publique Hopitaux De Marseille · Marseille · NCT07192315

• Tunlametinib for NRAS‑mutant non‑melanoma refractory solid tumors

  This trial tests tunlametinib to see if it can shrink or control advanced non‑melanoma solid tumors that have NRAS mutations in patients who have failed standard treatments.

  Recruiting Phase 2 Tianjin Medical University Second Hospital · Tianjin, Tianjin Municipality · NCT07170293

• xDRIVE personalized tumor testing for Florida cancer patients

  This program will try a functional precision medicine and AI platform (xDRIVE) to help guide next treatment options for Florida patients with recurrent or refractory cancer, including children and people from underserved communities.

  Recruiting First Ascent Biomedical Inc. · Miami, Florida and 1 other locations · NCT07167381

• Lattice radiation combined with immunotherapy for advanced solid tumors

  This trial will test whether combining lattice (spatially fractionated) radiation with immunotherapy helps people with advanced or metastatic solid tumors.

  Recruiting at 3 sites Phase 2 Tianjin Medical University Cancer Institute and Hospital · Beijing, Beijing Municipality and 2 other locations · NCT07058948

• Testing LXP1788 Injection for Advanced Solid Tumors

  This study is testing a new injection called LXP1788 to see if it can safely help people with advanced solid tumors that haven't responded to other treatments.

  Recruiting at 2 sites Phase 1 LaunXP Biomedical Co., Ltd. · Taichung and 1 other locations · NCT06883539

• Using 68Ga-PSMA-617 PET imaging for solid cancers

  This study is testing a new type of imaging called 68Ga-PSMA-617 to see if it can help doctors better detect and manage solid tumors that express PSMA, not just prostate cancer.

  Recruiting Centre de recherche du Centre hospitalier universitaire de Sherbrooke · Sherbrooke, Quebec · NCT05228106

• Monitoring immune responses and biomarkers in cancer immunotherapy

  This study is testing how well certain immune responses and markers in the blood can help predict how patients with advanced solid cancers respond to new immunotherapy treatments.

  Recruiting at 3 sites Institut Claudius Regaud · Toulouse and 2 other locations · NCT03514368

NIH-funded research (6)

Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.

• How tumor scaffolding proteins weaken natural killer cells

  This research explores how proteins that surround tumors change natural killer cells in people with breast or skin cancer.

  NIH research Massachusetts General Hospital · Boston, United States · NIH-11301905

• Reducing fat buildup in immune cells to help them fight solid tumors

  This work tries to help immune cells attack solid cancers by blocking an enzyme (ACC) that causes harmful fat storage in those cells.

  NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11239768

• Creating cancer models from pediatric brain and solid tumors

  This study is working to create new models of pediatric cancers, especially brain tumors like DIPG, to help researchers better understand these conditions and develop better treatments for kids battling cancer.

  NIH research Leidos Biomedical Research, INC. · Frederick, United States · NIH-11197551

• How natural killer cells interact with proteins in solid tumors

  This study is looking at how certain proteins in the body can affect immune cells that help fight cancers like skin and breast cancer, with the hope of finding new ways to improve treatments for patients.

  NIH research Massachusetts General Hospital · Boston, United States · NIH-11061935

• Improving immune function in solid tumors by altering fat metabolism

  This study is looking at how fat metabolism affects the immune system in cancer patients, specifically how a certain enzyme helps immune cells use fats for energy, with the hope of finding new ways to make these cells stronger in fighting cancer.

  NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11045948

• Developing a new antibody treatment for advanced lung cancer

  This study is looking at a new treatment called TIGA-001, which uses a special type of antibody to help your immune system fight advanced lung cancer, and if you're interested, you might have a chance to join future trials to see how well it works.

  NIH research Tigatx INC · Boston, United States · NIH-10919593

Related topics

Quick answers

How many Solid Cancers clinical trials are recruiting right now?

13, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 6 countries. The most sites are in China (5 trials), France (3 trials), United States (2 trials), Taiwan (1 trial), Canada (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 2, Phase 2: 2, Phase 1/2: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →